HAE 250117 90.00C (HAE250117C90000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

HAE250117C90000

Watchlist

0.25
-1.70-87.18%

15min DelayTrading Dec 23 09:30 ET

0.25High0.25Low

Intraday

5D
Daily

News

Earnings Grew Faster Than the Favorable 12% CAGR Delivered to Haemonetics (NYSE:HAE) Shareholders Over the Last Three Years
Simply Wall StDec 23 10:10 ET
Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE)
Zacks Dec 23 08:40 ET
Haemonetics: Strong Market Position and Attractive Investment Opportunity Amid Growth in Plasma and Hospital Segments
TipRanksDec 20 13:00 ET
Should You Continue to Hold TMO Stock in Your Portfolio?
Zacks Dec 11 07:00 ET
Are Investors Undervaluing Haemonetics (HAE) Right Now?
Yahoo FinanceDec 6 09:40 ET
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
BenzingaDec 6 08:17 ET

Comments

Moomoo AI

Mar 8 05:32

Despite a recent dip, Haemonetics' robust financials hint at potential long-term stock value growth. High ROE and profit reinvestment suggest promising earnings growth, with analysts predicting continued expansion.

Haemonetics Corporation (NYSE:HAE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Moomoo AI

Jan 29 05:09

Despite the falling share price, the consistent growth in revenue and EPS could present an investment opportunity if the stock has fallen unfairly. Market expectations may have been unreasonable in the past.

The Three-year Underlying Earnings Growth at Haemonetics (NYSE:HAE) Is Promising, but the Shareholders Are Still in the Red Over That Time

Moomoo AI

Jan 2 07:33

Shareholders appear to hang onto Haemonetics, expecting it to keep beating market trends, due to its projected solid growth. Despite a high P/E, the predicted limited risk of an earnings drop keeps the share price stable.

Getting In Cheap On Haemonetics Corporation (NYSE:HAE) Might Be Difficult

Moomoo Breakfast US

Aug 30, 2022 07:34

Columns Today's Pre-Market Stock Movers: BBY, BIDU, LCID, FSLR and More

Gapping up
In reaction to earnings/guidance:
• $Gambling.com (GAMB.US)$ +5.5%, $Baidu (BIDU.US)$ +3.6%, $Best Buy (BBY.US)$ +2.4%, $Heico (HEI.US)$ +1.4%, $Big Lots (BIG.US)$ +0.6%
Other news:
• $FREYR Battery (FREY.US)$ +11.4% (announces the execution of 38 GWh Li-Ion Battery binding cell sales agreement; enters into module & pack JV for energy storage solutions with Nidec)
• $Avid Technology (AVID.US)$ +9.6% (to join S&P SmallCap 600)
• $RVL Pharmaceuticals (RVLP.US)$ +2.3% (Re...

Moomoo Breakfast US

Aug 10, 2022 07:45

Columns Today's pre-market stock movers: RBLX, TTD, VLD, WYNN and more

Gainers:
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%,...